CLL: Should Anyone Still be Treated with Chemoimmunotherapy, Improving Efficacy and Safety of Ibrutinib by Combination or Using Different BTKi
By
Indy Hematology Review
FEATURING
Jennifer Woyach
By
Indy Hematology Review
FEATURING
Jennifer Woyach
Login to view comments.
Click here to Login